<ѻýҕl>What Is Causing This Woman's Swollen Chin?ѻýҕl> A long and challenging diagnostic path with twists and turns Jan 20, 2020
<ѻýҕl>Higher Risk of Shingles Seen in Patients With Certain Cancersѻýҕl> Vaccine development may help with prevention of herpes zoster in this population Dec 31, 2019
<ѻýҕl>'Dark Waters': Behind-the-Scenes With Attorney Who Took on DuPontѻýҕl> Chemical in Teflon was "completely unregulated" when Robert Bilott went after corporate giant Dec 19, 2019
<ѻýҕl>Denosumab Use in Myeloma Soars for No Obvious Reasonѻýҕl> More expensive than competitor without being better, so why does it now have nearly half the market? Dec 12, 2019
<ѻýҕl>Survival Bump With Oral AML Maintenanceѻýҕl> Ten-month OS gain, doubling of RFS with oral azacitidine in transplant-ineligible patients Dec 10, 2019
<ѻýҕl>'Off-the-Shelf' Therapy Active After CAR T-Cell Failureѻýҕl> Bispecific antibody mosunetuzumab targets CD3, CD20; needs no ex vivo T-cell processing Dec 07, 2019
<ѻýҕl>Study Bolsters Case for Novel Xarelto Formulation for Kidsѻýҕl> Pharmacokinetic data indicate appropriate dosing schemes across wide range of weight categories Dec 07, 2019
<ѻýҕl>IGHV-Unmutated CLL: Gene Signature May Predict Outcomes After First-Line FCRѻýҕl> Prognostic tool may predict who is likely to achieve a relatively long remission Oct 15, 2019
<ѻýҕl>FCR Still an Option in IGHV-Unmutated CLL?ѻýҕl> Gene signature identifies lower-risk group with greater chemoimmunotherapy benefit Oct 08, 2019
<ѻýҕl>Ibrutinib's Cardiotoxicity Comes Into Focusѻýҕl> Study identifies new cardiac events linked to so-called targeted therapy Sep 25, 2019
<ѻýҕl>Red Cell Distribution Width Strongly Predicts Hip Fractureѻýҕl> Simple way to identify at-risk patients Sep 24, 2019
<ѻýҕl>Could Mom's Anemia Hurt Baby's Brain?ѻýҕl> Association study suggests an increased risk, though still quite small Sep 18, 2019
<ѻýҕl>Good News, Bad News for CRISPR Gene Editing for HIV Cureѻýҕl> "Bigger story for the gene-editing field than the HIV field" Sep 11, 2019
<ѻýҕl>Serum Immune Markers May Predict Conversion From MGUS to Myelomaѻýҕl> Results could support annual blood tests and risk assessment for those with MGUS and its subtype, light-chain MGUS Jul 19, 2019
<ѻýҕl>TAVR Access Closure Devices Not Equal, Study Showsѻýҕl> Separate study suggests bleed monitoring device could help May 23, 2019
<ѻýҕl>Enoxaparin May Be Underdosed for CRC Surgery Patientsѻýҕl> Standard dose yielded low anticoagulation levels in 68% but no increase in venous thromboembolism May 23, 2019
<ѻýҕl>Rheumatologist's Primer on Checkpoint Inhibitorsѻýҕl> Specialist reviews the landscape of cancer drugs' autoimmune side effects Apr 09, 2019
<ѻýҕl>Bone Marrow Transplant for Autoimmune Disease: Ready for Prime Time?ѻýҕl> Everything you know about BMT is probably wrong, says hematologist Apr 08, 2019
<ѻýҕl>Durable Responses With Keytruda in Later-Line SCLCѻýҕl> Plus umbralisib in marginal zone lymphoma and a next-generation TRK-targeted agent Apr 04, 2019
<ѻýҕl>Overall Survival Data in for Gilteritinib as AML Salvage Txѻýҕl> FLT3 Inhibitor tops chemotherapy in randomized trial Apr 01, 2019
<ѻýҕl>Transplant No Help in Hypodiploid ALLѻýҕl> Similar 5-year outcomes with or without HSCT, regardless of MRD status Mar 29, 2019
<ѻýҕl>Are Patients Better Off With Image-Guided Bone Marrow Biopsy?ѻýҕl> Prospect of sedation has some going to interventional radiology Mar 29, 2019
<ѻýҕl>Ticagrelor Antidote Clears Phase I Trialѻýҕl> Quick reversal of P2Y12 inhibitor possible in healthy participants Mar 17, 2019
<ѻýҕl>Andexanet Holds Strong as Antidote to Apixaban, Rivaroxabanѻýҕl> Reversal agent for factor Xa inhibitors soon to be subject to a randomized trial Feb 08, 2019
<ѻýҕl>Increased Risk of Chemo-Associated AML for Nearly All Solid Cancersѻýҕl> Extended beyond 5 years for most types with greater risk seen in young patients Dec 20, 2018
<ѻýҕl>Higher Risk of Shingles Seen in Patients With Certain Cancersѻýҕl> Vaccine development may help with prevention of herpes zoster in this population Dec 14, 2018
<ѻýҕl>In Lupus, Risks for Cancers Riseѻýҕl> Overall risks increased for both women and men Dec 07, 2018
<ѻýҕl>ASH Poster Rounds: Adding BTK Inhibitor Safe in First-Line MCLѻýҕl> Plus: Lenalidomide upfront in PTCL; skipping RT in primary mediastinal B-cell lymphoma Dec 07, 2018
<ѻýҕl>ASH Poster Rounds: Obesity Impacts CLL Survival in Womenѻýҕl> Plus: New risk model predicts CLL survival; novel BTK inhibitor works after ibrutinib Dec 06, 2018
<ѻýҕl>Cancer-VTE Trial Falls Shortѻýҕl> High dropout rate undermines rivaroxaban prophylaxis trial Dec 05, 2018
<ѻýҕl>Combination Regimen Extends PFS in Myelomaѻýҕl> Large benefit but relevance of comparator questioned Dec 04, 2018
<ѻýҕl>$2 Test Could Transform Sickle Cell Dx in Africaѻýҕl> May have applications in high-income countries as well Dec 04, 2018
<ѻýҕl>ASH Offers Early Look at Updated SCD Guidelinesѻýҕl> Experts formulated >50 recommendations on sickle cell disease Dec 03, 2018
<ѻýҕl>CAR T-Cell Responses Prove Durable in ALL, DLBCLѻýҕl> Two studies demonstrate long-term control in relapsed/refractory disease Dec 01, 2018
<ѻýҕl>Sneak Peek at Practice-Changing Research From ASH 2018ѻýҕl> "Big trials, big results," plus sickle cell disease and CAR T-cell therapies Nov 30, 2018
<ѻýҕl>LMWH Prevails for VTE Prevention in Guidelineѻýҕl> ASH unveils first six chapters of comprehensive recommendations Nov 29, 2018
<ѻýҕl>FDA Approves Rituximab Biosimilar for NHLѻýҕl> Indications for front line or beyond, single agent or combination Nov 28, 2018
<ѻýҕl>Deaths from Non-Obesity-Related Cancers Higher in T2Dѻýҕl> Even in some obesity-related malignancies, high BMI was inversely tied to cancer death Oct 03, 2018
<ѻýҕl>Sickle Cell in the ED: Old Therapies, New Strategiesѻýҕl> With treatments unchanged in decades, docs seek to improve delivery Oct 02, 2018